| ID | Sequence | Length | GC content |
|---|---|---|---|
| ACAGAGUCCCAGGGAGUCCCACCAGCCUAGUCGCCAGACCUUCUGUGGG… | 4286 nt | 0.4991 | |
| ACAGAGUCCCAGGGAGUCCCACCAGCCUAGUCGCCAGACCUUCUGUGGG… | 1941 nt | 0.5358 | |
| ACAGAGUCCCAGGGAGUCCCACCAGCCUAGUCGCCAGACCUUCUGUGGG… | 2022 nt | 0.5336 | |
| GUGGCCGCCCAGGCUCCAGACAGGCCAGGGGAGGAUCACGAGGAGCUGC… | 4267 nt | 0.5027 | |
| AGAUAAGGGCACUGAGGCUGAGAGAGGAGCUGAAACCUACCCGGGGUCA… | 4155 nt | 0.5338 | |
| GUGGCCGCCCAGGCUCCAGACAGGCCAGGGGAGGAUCACGAGGAGCUGC… | 4470 nt | 0.5089 | |
| ACAGAGUCCCAGGGAGUCCCACCAGCCUAGUCGCCAGACCUUCUGUGGG… | 2210 nt | 0.5348 |
This gene encodes a member of the bestrophin gene family. This small gene family is characterized by proteins with a highly conserved N-terminus with four to six transmembrane domains. Bestrophins may form chloride ion channels or may regulate voltage-gated L-type calcium-ion channels. Bestrophins are generally believed to form calcium-activated chloride-ion channels in epithelial cells but they have also been shown to be highly permeable to bicarbonate ion transport in retinal tissue. Mutations in this gene are responsible for juvenile-onset vitelliform macular dystrophy (VMD2), also known as Best macular dystrophy, in addition to adult-onset vitelliform macular dystrophy (AVMD) and other retinopathies. Alternative splicing results in multiple variants encoding distinct isoforms.[provided by RefSeq, Nov 2008]
No relevant information is available at the moment.